Suppr超能文献

相似文献

2
Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis.
Bioorg Med Chem. 2012 Mar 15;20(6):2131-40. doi: 10.1016/j.bmc.2012.01.024. Epub 2012 Jan 31.
3
Design, Synthesis, and Pharmacokinetics of a Bone-Targeting Dual-Action Prodrug for the Treatment of Osteoporosis.
J Med Chem. 2017 Aug 24;60(16):7012-7028. doi: 10.1021/acs.jmedchem.6b00951. Epub 2017 Aug 10.
4
Targeting therapeutics to bone by conjugation with bisphosphonates.
Curr Opin Pharmacol. 2018 Jun;40:87-94. doi: 10.1016/j.coph.2018.03.010. Epub 2018 Apr 4.
6
Determination of the rat in vivo pharmacokinetic profile of a bone-targeting dual-action pro-drug for treatment of osteoporosis.
Bioconjug Chem. 2015 Jun 17;26(6):1095-103. doi: 10.1021/acs.bioconjchem.5b00160. Epub 2015 May 15.
8
In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss.
Osteoporos Int. 2016 Feb;27(2):797-808. doi: 10.1007/s00198-015-3284-x. Epub 2015 Aug 14.
10
Osteopontin deficiency enhances anabolic action of EP4 agonist at a sub-optimal dose in bone.
J Endocrinol. 2007 Apr;193(1):171-82. doi: 10.1677/joe.1.06917.

引用本文的文献

1
Hydroxy- and Amino-Phosphonates and -Bisphosphonates: Synthetic Methods and Their Biological Applications.
Front Chem. 2022 Jun 1;10:890696. doi: 10.3389/fchem.2022.890696. eCollection 2022.

本文引用的文献

1
Achieving enhanced bone regeneration using monetite granules with bone anabolic drug conjugates (C3 and C6) in rat mandibular defects.
J Biomed Mater Res B Appl Biomater. 2020 Aug;108(6):2670-2680. doi: 10.1002/jbm.b.34598. Epub 2020 Mar 11.
3
Medication-Related Osteonecrosis of the Jaws.
J Natl Cancer Inst Monogr. 2019 Aug 1;2019(53). doi: 10.1093/jncimonographs/lgz009.
5
The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years.
Osteoporos Int. 2018 Oct;29(10):2335-2343. doi: 10.1007/s00198-018-4604-8. Epub 2018 Jul 5.
6
Design, Synthesis, and Pharmacokinetics of a Bone-Targeting Dual-Action Prodrug for the Treatment of Osteoporosis.
J Med Chem. 2017 Aug 24;60(16):7012-7028. doi: 10.1021/acs.jmedchem.6b00951. Epub 2017 Aug 10.
7
In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss.
Osteoporos Int. 2016 Feb;27(2):797-808. doi: 10.1007/s00198-015-3284-x. Epub 2015 Aug 14.
8
Determination of the rat in vivo pharmacokinetic profile of a bone-targeting dual-action pro-drug for treatment of osteoporosis.
Bioconjug Chem. 2015 Jun 17;26(6):1095-103. doi: 10.1021/acs.bioconjchem.5b00160. Epub 2015 May 15.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验